From Site-Specific Conjugation to Linker−Payload Presentation: Lessons from AJICAP and Exo-Linker for Antibody−Drug Conjugate Pharmaceutical Design
Year: 2026
Type: article
Source: Molecular Pharmaceutics
Institution: Ajinomoto (Japan)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7225746561
